Summary by Futu AI
Deqi Pharmaceuticals Co., Ltd. ("Deqi Pharmaceuticals-B") will hold a board of directors meeting on August 23, 2024 to consider and approve the mid-term performance ending on June 30, 2024 and its release. The meeting will be chaired by Dr. Meijianming, the chairman of the board of directors, and will be announced on August 1, 2024. Currently, the board of directors of Deqi Pharmaceuticals includes executive directors Dr. Meijianming and Mr. Long Zhenguo, as well as independent non-executive directors Ms. Qian Jing, Mr. Tang Sheng and Dr. Rafael Fonseca.